Abstract:Objective To explore the occurrence site, clinical manifestations, endoscopic and radiographic features, pathologic characteristics, diagnosis, treatment and prognosis of gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN).Methods From January 2000 to June 2010,medical records of 87 GEP-NEN patients in the First Affiliated Hospital of Sun Yat-sen University were collected. The neuroendocrine properties of the tumors were determined by immunohistochemistry staining of neuroendocrine markers Syn and CgA.Then according to histology and proliferation activity, the GEP-NEN tumors were classified as neuroendocrine tumor (G1 and G2 grade), neuroendocrine carcinoma (G3 grade) and mixed adenoendocrine carcinoma (G3 grade).Results 36 cases (41.4％) of GEP-NEN tumors were in pancreas, followed by 18 cases in rectum (20.7％), 9 cases in stomach (10.3％) and 6 cases in duodenum (6.9％).Total 69 of 87 GEP-NEN cases (74.7％) were nonfunctional tumors, a variety of gastrointestinal symptoms or symptoms caused by local tumor compression were the most first symptoms, and no one case presented carcinoid syndrome.The manifestations of endoscopy and radiographic image were tumor occupying lesion.Of 87 GEP-NEN cases, 69 cases were neuroendocrine tumor (79.7％), 13 cases were neuroendocrine carcinoma (14.9％) and 5 cases were mixed adenoendocrine carcinoma (5.4％).The percentage of grade G1, G2 and G3 tumors were 64.9％、 14.9％ and 20.2％ respectively.Muscularis or serosa infiltration were found in 22 GEP-NEN patients (47.8％) at the first visit, lymphatic metastasis was in 18 cases (20.7％) and distant metastasis were in 18 cases (20.7％), mostly migrated to liver.Immunohistochemistry staining positive rates of CgA and Syn were 74.2％ and 88.1％.A total of 79 patients (90.8％) were underwent surgery.The 1-, 3-and 5-year survival rates were 76.9％, 54.2％and 41.7％ during follow-up.Conclusions GEP-NEN may occur at any part of the digestive system,the clinical manifestations are variable.Endoscopy and radiographic examination play an important role in tumor diagnosis, but final diagnosis is mainly based on pathological detection, and surgery is the main treatment option.The prognosis of the tumor is correlated with the pathological classification,grading and condition of distant metastasis.

Research Progress on Treatment of Duodenal Neuroendocrine Neoplasm

The application significance of endoscopic ultrasonography and endoscopic submucosal dissection in upper digestive tract neuroendocrine tumor

Role of Surgical Treatments in High-Grade or Advanced Gastroenteropancreatic Neuroendocrine Neoplasms.

Progress of Drug Treatment for Gastrointestinal Neuroendocrine Neoplasm

The Advance in Research into Immunotherapy for Neuroendocrine Carcinoma of Digestive System

Advances in Endoscopic Diagnosis and Treatment of Gastric Neuroendocrine Neoplasms.

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Progress of diagnosis and treatment for gastrointestinal neuroendocrine neoplasms

Current Treatment Status In Pancreatic Neuroendocrine Neoplasms

Treatment outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumors

Clinicopathologic Characteristics and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms: a Multicenter Study in South China

Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives

Clinical application of traditional Chinese medicine in the treatment of neuroendocrine neoplasms

Advances in Medical Treatment for Pancreatic Neuroendocrine Neoplasms

[Advances of Circulating Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms].

Progress of Diagnosis and Treatment of Gastrointestinal Neuroendocrine Tumors

Updates on Medical Treatment for Neuroendocrine Neoplasm

Neuroendocrine Neoplasms of the Major Duodenal Papilla with Focus on Histopathological Features and Prognosis

Clinicopathological features and prognostic factors of neuroendocrine neoplasms at different sites in the digestive system

The analysis of the diagnosis and treatment of 87 gastroenteropancreatic neuroendocrine neoplasm eases

Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach